MDBI

TrivarX Limited (MDBIF)

Market Closed
5 Dec, 20:00
OTC PINK OTC PINK
$
0. 02
0
0%
$
8.34M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
$ 0.02
Previous Close
Day Range
0.02 0.02
Year Range
0 0.02
Want to track MDBIF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MDBIF closed Friday higher at $0.02, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, MDBIF stock gained 647.62%.
MDBIF is not paying dividends to its shareholders.
The last earnings report, released on Feb 26, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
TrivarX Limited has completed 1 stock splits, with the recent split occurring on Oct 24, 2023.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

MDBIF Chart

TrivarX Limited (MDBIF) FAQ

What is the stock price today?

The current price is $0.02.

On which exchange is it traded?

TrivarX Limited is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is MDBIF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 8.34M.

Has TrivarX Limited ever had a stock split?

TrivarX Limited had 1 splits and the recent split was on Oct 24, 2023.

TrivarX Limited Profile

Mortgage Real Estate Investment Trusts (REITs) Industry
Financials Sector
Mr. Kai Sun CEO
OTC PINK Exchange
AU000000MEB8 ISIN
United Kingdom Country
1,411 Employees
- Last Dividend
24 Oct 2023 Last Split
- IPO Date

Overview

TrivarX Limited, initially known as Medibio Limited, is a pioneering health technology company focused on the advancement of mental health care through innovative detection and screening technologies. Founded in 1987 and headquartered in Mount Lawley, Australia, the company has expanded its operations to both Australia and the United States. With a strong commitment to improving mental well-being, TrivarX Limited serves a dual market comprising both businesses seeking corporate health solutions and healthcare providers looking for effective tools in mental health diagnosis and management. In October 2023, the company underwent a significant rebranding to TrivarX Limited, marking a new chapter in its mission to enhance mental health care globally.

Products and Services

TrivarX Limited offers a range of innovative solutions designed to support mental well-being in various settings:

  • Corporate Health Product: This service is tailored for businesses aiming to safeguard and enhance the mental health of their employees. By integrating TrivarX's cutting-edge technologies, companies can access effective tools for early detection and ongoing screening of mental health conditions, thereby fostering a healthier workplace environment.
  • Healthcare Provider Products: Developed with healthcare professionals in mind, these products facilitate the accurate assessment and management of mental health conditions. TrivarX Limited leverages advanced technology to provide reliable, evidence-based solutions that aid in the diagnostic process, offering a valuable resource for practitioners in the mental health field.

Contact Information

Address: 51 Homer Road
Phone: 44 34 5849 4000